Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite.

Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
Jan 2019
Historique:
pubmed: 16 12 2018
medline: 16 12 2018
entrez: 16 12 2018
Statut: ppublish

Résumé

In the version of this article originally published, data were incorrectly ascribed to monoclonal antibody CIS34 because of a labeling error. The data were generated with monoclonal antibody CIS04. Full details can be found in the correction notice.

Identifiants

DOI: 10.1038/s41591-018-0315-0 PMID: 30552419
pubmed: 30552419
doi: 10.1038/s41591-018-0315-0
pii: 10.1038/s41591-018-0315-0
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

188-189

Commentaires et corrections

Type : ErratumFor

Auteurs

Neville K Kisalu (NK)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Azza H Idris (AH)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Connor Weidle (C)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

Yevel Flores-Garcia (Y)

Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Barbara J Flynn (BJ)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Brandon K Sack (BK)

Seattle Biomedical Research Institute, Seattle, Washington, USA.
ORCID: 0000-0002-5577-7787

Sean Murphy (S)

Seattle Biomedical Research Institute, Seattle, Washington, USA.

Arne Schön (A)

Department of Biology, Johns Hopkins University, Baltimore, Maryland, USA.

Ernesto Freire (E)

Department of Biology, Johns Hopkins University, Baltimore, Maryland, USA.

Joseph R Francica (JR)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Alex B Miller (AB)

Division of Health Sciences and Technology, Institute for Medical Engineering and Science, and The Broad Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

Jason Gregory (J)

Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Sandra March (S)

Division of Health Sciences and Technology, Institute for Medical Engineering and Science, and The Broad Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

Hua-Xin Liao (HX)

Duke Human Vaccine Institute, Durham, North Carolina, USA.
College of Life Science and Technology, Jinan University, Guangzhou, China.

Barton F Haynes (BF)

Duke Human Vaccine Institute, Durham, North Carolina, USA.
Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
Department of Immunology, Duke University Medical Center, Durham, North Carolina, USA.

Kevin Wiehe (K)

Duke Human Vaccine Institute, Durham, North Carolina, USA.
Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.

Ashley M Trama (AM)

Duke Human Vaccine Institute, Durham, North Carolina, USA.

Kevin O Saunders (KO)

Duke Human Vaccine Institute, Durham, North Carolina, USA.
Department of Surgery, Duke University School of Medicine, Duke University Medical Center, Durham, North Carolina, USA.

Morgan A Gladden (MA)

Duke Human Vaccine Institute, Durham, North Carolina, USA.

Anthony Monroe (A)

Duke Human Vaccine Institute, Durham, North Carolina, USA.

Mattia Bonsignori (M)

Duke Human Vaccine Institute, Durham, North Carolina, USA.
Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.

Masaru Kanekiyo (M)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
ORCID: 0000-0001-5767-1532

Adam K Wheatley (AK)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

Adrian B McDermott (AB)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

S Katie Farney (SK)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Gwo-Yu Chuang (GY)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Baoshan Zhang (B)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Natasha Kc (N)

Sanaria Inc., Rockville, Maryland, USA.

Sumana Chakravarty (S)

Sanaria Inc., Rockville, Maryland, USA.

Peter D Kwong (PD)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Photini Sinnis (P)

Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Sangeeta N Bhatia (SN)

Division of Health Sciences and Technology, Institute for Medical Engineering and Science, and The Broad Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

Stefan H I Kappe (SHI)

Seattle Biomedical Research Institute, Seattle, Washington, USA.

B Kim Lee Sim (BKL)

Sanaria Inc., Rockville, Maryland, USA.
ORCID: 0000-0002-8598-8905

Stephen L Hoffman (SL)

Sanaria Inc., Rockville, Maryland, USA.

Fidel Zavala (F)

Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Marie Pancera (M)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. mpancera@fredhutch.org.

Robert A Seder (RA)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. rseder@mail.nih.gov.

Classifications MeSH